SGC Press Releases

$5 million in funding for research into malaria and tuberculosis drug discovery

Wednesday 16th December 2015

University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.

Takeda renews partnership with Structural Genomics Consortium at MaRS Toronto with new investment of $7.5 million

Friday 4th December 2015

Takeda Pharmaceutical Company Limited (Takeda) today announced it has renewed its partnership with the Structural Genomics Consortium (SGC) to fund collective drug research aimed at bringing new, more effective medicines to patients faster.

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research.

Thursday 3rd September 2015

Through a novel open source approach the molecule has been made freely available to the cancer research community to help discover new therapeutic strategies for cancer patients sooner.

ULTRA-DD – Collaborative open source consortium to validate new targets for drug discovery

Monday 25th May 2015

Pharmaceutical companies who are members of the European Federation of Pharmaceutical Industries and Associations (EFPIA) join forces with small and medium-sized enterprise (SMEs) as well as universities and hospitals in an Innovative Medicines Initiative (IMI) supported public private partnership, ULTRA-DD. In this project, we aim to define and validate new drug targets in inflammatory and auto-immune diseases by testing high quality chemical probes and antibodies in patient-cell derived assays to facilitate a greater understanding of disease pathology.

Open-source partnership to uncover role of epigenetic regulation in Rett Syndrome

Friday 17th April 2015

Toronto, ON (April 17^th, 2015) - The Structural Genomics Consortium (SGC) at the University of Toronto and the Ontario Brain Institute (OBI) have entered into an “open-source” research partnership with two Toronto-based hospitals to test tool compounds, called chemical probes, against epigenetic proteins in research models of Rett syndrome.

Open-Source Scientific Research Comes to Brazil

Tuesday 10th March 2015

Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world. A $4.3-million (USD) grant from the São Paulo Research Foundation (FAPESP) plus an in-kind contribution of US$ 1.9 million by The University of Campinas (UNICAMP), totalling US$ 6,2 million, will establish Brazil’s first open-access research facility, the Protein Kinase Chemical Biology Centre at the UNICAMP in Brazil.

Alzheimer's: £30m dementia research alliance launched

Wednesday 25th February 2015

A new Drug Discovery Institute in Oxford focusing on finding new medicines for Azheimer’s is being funded by Alzheimer’s Research UK. The SGC will play a major role in this Institute, providing our expertise in protein production, protein crystallography and medicinal chemistry.

Merck Announces a Contribution of $7.5 Million to the Structural Genomics Consortium (SGC) Toronto

Wednesday 4th February 2015

This morning at MaRS Discovery District, Merck confirmed its commitment to research and innovation with a $7.5 million contribution to the Structural Genomics Consortium Toronto. (From left to right) Dr. Ronan O'Hagan, Dr. Aled Edwards, The Honourable Reza Moridi, Mr. Chirfi Guindo and Ms. Jennifer Chan. (CNW Group/Merck)

SGC Director Aled Edwards: Scientist Turned Social Entrepreneur Elected Senior Ashoka Fellow

Monday 15th December 2014

TORONTO, ON (December 9, 2014) — Dr. Aled Edwards, co-founder and CEO of Structural Genomics Consortium (SGC), has been elected a Senior Ashoka Fellow.

New support for structure-guided drug discovery coalition research on tropical diseases

Monday 24th November 2014

$2 million grant from the Bill & Melinda Gates Foundation furthers existing research on malaria and TB

Toronto, ON --Almost $2 million is being invested by the Bill & Melinda Gates Foundation to help fight major parasitic diseases of the developing world.